Investors / United States / 120 Capital
120 Capital
Venture capital · United States · North America
120 Capital is a life science and healthcare venture fund. It invests in portfolio companies and reports on their financings, clinical trials, partnerships and acquisitions.
Invests inHealthcare & Biotech
In its own wordslife scienceshealthcarebiotechtherapeuticsoncology
Your fit with 120 Capital
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fits120 Capital lists 9 checked portfolio companies on its own site. Its largest theme is Healthcare & Biotech (100%). 67% of its companies are based in United States. It invests most often alongside ARCH Venture Partners, 3E Bioventures Capital and Agent Capital.
No funding round on record names 120 Capital yet, so the figures come from its portfolio page.
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 19th | 9 companies |
| Recent activity | 46th | 0 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 100th | 100% in its largest sector |
| Reach | 42th | 2 countries |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers889%
- No longer answers00%
- Points to another company111%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 100% | 15% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with ARCH Venture Partners
Compare 120 Capital head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Portfolio
9 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| C-Ray Therapeutics focuses on providing full-process and integrated services for radiopharmaceuticals from pre-clinical to clinical transformation. | Healthcare & Biotech | Portfolio page | ||
| Dewpoint Therapeutics develops first-in-class condensate modulator therapies for intractable targets, including cancer and ALS. | Healthcare & Biotech | Portfolio page | ||
| Exo Therapeutics develops breakthrough medicines by modulating enzyme activity in oncology and inflammation with precision and potency | Healthcare & Biotech | Portfolio page | ||
Healthcare & Biotech | Portfolio page | |||
| HiberCell develops therapeutic candidates to target the integrated stress response in cancer treatment. | Healthcare & Biotech | Portfolio page | ||
| The company develops and provides innovative drugs and solutions for brain disease treatment. | Healthcare & Biotech | Portfolio page | ||
| Immunitas Therapeutics discovers and develops novel therapeutics for patients with cancer and autoimmune diseases. | Healthcare & Biotech | Portfolio page | ||
| Kira Pharmaceuticals is a clinical-stage biotechnology company developing therapies for patients with complement-mediated diseases. | Healthcare & Biotech | Portfolio page | ||
| Senti Bio is a clinical-stage company developing a new generation of cell and gene therapies for patients living with incurable diseases. | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- 120capital.com
- Last read
- 5 Nov 2026
- Watching since
- 6 Nov 2026
- Companies checked
- 9
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get 120 Capital's profile as data
Pull 120 Capital's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/120capital.com
# also
GET /v1/firms/120capital.com/portfolio
GET /v1/firms/120capital.com/coinvestors
GET /v1/firms/120capital.com/news